Newborn screening for sickle cell disease: whose reproductive benefit?

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

6 citing papers in PubMed.

1. Newborn Screening for Sickle Cell Disease and Other Hemoglobinopathies: A Short Review on Classical Laboratory Methods-Isoelectric Focusing, HPLC, and Capillary Electrophoresis.International journal of neonatal screening · 2018
   Review
2. Fostering caring relationships: Suggestions to rethink liberal perspectives on the ethics of newborn screening.Bioethics · 2018
   Review
3. A qualitative study to explore how professionals in the United Kingdom make decisions to test children for a sickle cell carrier status.European journal of human genetics : EJHG · 2016
   Article
4. Disparities in current and future childhood and newborn carrier identification.Journal of genetic counseling · 2014
   Article
5. Reflecting on earlier experiences with unsolicited findings: points to consider for next-generation sequencing and informed consent in diagnostics.Human mutation · 2013
   Review
6. Reply to Ross' commentary: Reproductive benefit through newborn screening: preferences, policy and ethics.European journal of human genetics : EJHG · 2012
   Article

Corrections and comments

• Commented on by
  Reply to Ross' commentary: Reproductive benefit through newborn screening: preferences, policy and ethics.2012
• Comment on
  Health-care providers' views on pursuing reproductive benefit through newborn screening: the case of sickle cell disorders.2012

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as